Tailored nutrition therapy (From Penniston and Nakada [32])
References
1.
Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997;12:522–33.CrossrefPubMed
2.
Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51:894–900.CrossrefPubMed
3.
Lifshitz DA, Shalhav AL, Lingeman JE, et al. Metabolic evaluation of stone disease patients: a practical approach. J Endourol. 1999;13:669–78.CrossrefPubMed
4.
Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron. 1999;81(Suppl 1):31–7.CrossrefPubMed
5.
Goldfarb DS, Coe FL. Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999;33:398–400. discussion 401–3CrossrefPubMed
6.
Strauss AL, Coe FL, Deutsch L, et al. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982;72:17–24.CrossrefPubMed
7.
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.CrossrefPubMed
8.
Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996;143:240–7.CrossrefPubMed
9.
Prince CL, Scardino PL. A statistical analysis of ureteral calculi. J Urol. 1960;83:561–5.CrossrefPubMed
10.
Mandel NS, Mandel GS. Urinary tract stone disease in the United States veteran population. I. Geographical frequency of occurrence. J Urol. 1989;142:1513–5.CrossrefPubMed
11.
Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–9.CrossrefPubMed
Only gold members can continue reading. Log In or Register to continue